131 related articles for article (PubMed ID: 25195010)
1. Kinase inhibitors: an allosteric add-on.
Foda ZH; Seeliger MA
Nat Chem Biol; 2014 Oct; 10(10):796-7. PubMed ID: 25195010
[No Abstract] [Full Text] [Related]
2. A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics.
Chaikuad A; Tacconi EM; Zimmer J; Liang Y; Gray NS; Tarsounas M; Knapp S
Nat Chem Biol; 2014 Oct; 10(10):853-60. PubMed ID: 25195011
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of BRAF and ERK1/2 has synergistic effects on thyroid cancer growth in vitro and in vivo.
Hicks HM; McKenna LR; Espinoza VL; Pozdeyev N; Pike LA; Sams SB; LaBarbera D; Reigan P; Raeburn CD; E Schweppe R
Mol Carcinog; 2021 Mar; 60(3):201-212. PubMed ID: 33595872
[TBL] [Abstract][Full Text] [Related]
4. Retrieval mediated by hippocampal extracellular signal-regulated kinase/mitogen-activated protein kinase is required for memory strengthening.
Roesler R; Quevedo J
Neuroscience; 2009 Jun; 160(4):711-5. PubMed ID: 19298845
[TBL] [Abstract][Full Text] [Related]
5. Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway.
He M; Xue ZM; Li J; Zhou BQ
Acta Pharmacol Sin; 2012 May; 33(5):606-14. PubMed ID: 22465949
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2).
Li L; Liu F; Jin N; Tang S; Chen Z; Yang X; Ding J; Geng M; Jiang L; Huang M; Cao J
Bioorg Med Chem Lett; 2016 Jun; 26(11):2600-4. PubMed ID: 27106711
[TBL] [Abstract][Full Text] [Related]
7. cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway.
Shen B; Kwan HY; Ma X; Wong CO; Du J; Huang Y; Yao X
J Biol Chem; 2011 Jun; 286(22):19439-45. PubMed ID: 21487005
[TBL] [Abstract][Full Text] [Related]
8. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway.
Dokladda K; Green KA; Pan DA; Hardie DG
FEBS Lett; 2005 Jan; 579(1):236-40. PubMed ID: 15620719
[TBL] [Abstract][Full Text] [Related]
9. Development of anticancer drugs targeting the MAP kinase pathway.
Sebolt-Leopold JS
Oncogene; 2000 Dec; 19(56):6594-9. PubMed ID: 11426644
[TBL] [Abstract][Full Text] [Related]
10. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
Rice PL; Peters SL; Beard KS; Ahnen DJ
Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
[TBL] [Abstract][Full Text] [Related]
11. A sensitive flow cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells.
Rouget R; Auclair Y; Loignon M; Affar el B; Drobetsky EA
J Biol Chem; 2008 Feb; 283(9):5533-41. PubMed ID: 18093981
[TBL] [Abstract][Full Text] [Related]
12. YKL-40 augments the proliferation of HaCaT cells via the extracellular regulatory kinase pathway.
Suzuki H; Miyagaki T; Sato S
J Dermatol; 2019 Jun; 46(6):551-552. PubMed ID: 31021016
[No Abstract] [Full Text] [Related]
13. Magnolin Inhibits Proliferation and Invasion of Breast Cancer MDA-MB-231 Cells by Targeting the ERK1/2 Signaling Pathway.
Wang J; Zhang S; Huang K; Shi L; Zhang Q
Chem Pharm Bull (Tokyo); 2020; 68(5):421-427. PubMed ID: 32378540
[TBL] [Abstract][Full Text] [Related]
14. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia.
George AA; Paz H; Fei F; Kirzner J; Kim YM; Heisterkamp N; Abdel-Azim H
PLoS One; 2015; 10(9):e0137917. PubMed ID: 26360058
[TBL] [Abstract][Full Text] [Related]
15. BCR/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells.
Chu S; Holtz M; Gupta M; Bhatia R
Blood; 2004 Apr; 103(8):3167-74. PubMed ID: 15070699
[TBL] [Abstract][Full Text] [Related]
16. Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β
Baltes F; Caspers J; Henze S; Schlesinger M; Bendas G
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668815
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the MAPK/ERK pathway and neurocyte apoptosis after cerebral infarction in rats.
Wang QC; Lu L; Zhou HJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5374-5381. PubMed ID: 31298390
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity.
Tang Z; Jiang S; Du R; Petri ET; El-Telbany A; Chan PS; Kijima T; Dietrich S; Matsui K; Kobayashi M; Sasada S; Okamoto N; Suzuki H; Kawahara K; Iwasaki T; Nakagawa K; Kawase I; Christensen JG; Hirashima T; Halmos B; Salgia R; Boggon TJ; Kern JA; Ma PC
Oncogene; 2009 Jan; 28(4):518-33. PubMed ID: 19015641
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
Sun Y; Sinicrope FA
Mol Cancer Ther; 2005 Jan; 4(1):51-9. PubMed ID: 15657353
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic roles of the ERK and p38 MAPK signalling pathways in globin expression, haem biosynthesis and iron uptake.
Mardini L; Gasiorek J; Derjuga A; Carrière L; Schranzhofer M; Paw BH; Ponka P; Blank V
Biochem J; 2010 Nov; 432(1):145-51. PubMed ID: 20738258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
